[Adrenomedullin: vascular action].
Ozawa
Naoko
N
Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School.
Shichiri
Masayoshi
M
D053607:Adrenomedullin; D000818:Animals; D017209:Apoptosis / Q000235:genetics; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D050976:Basic-Leucine Zipper Transcription Factors; D002455:Cell Division; D000242:Cyclic AMP / Q000502:physiology; D004268:DNA-Binding Proteins / Q000502:physiology; D042783:Endothelial Cells / Q000166:cytology; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D018919:Neovascularization, Physiologic; D010455:Peptides / Q000502:physiology*; D016271:Proto-Oncogene Proteins c-myc / Q000502:physiology; D014157:Transcription Factors / Q000502:physiology; D014158:Transcription, Genetic; D014664:Vasodilation
D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D050976:Basic-Leucine Zipper Transcription Factors; D004268:DNA-Binding Proteins; C499330:MAX protein, human; C067850:Myc associated factor X; D010455:Peptides; D016271:Proto-Oncogene Proteins c-myc; D014157:Transcription Factors; D053607:Adrenomedullin; D000242:Cyclic AMP